Abstract
Abstract
Background
Hepatitis B (HBV) and hepatitis C (HCV) viruses are diseases of global public health concern and are associated with liver cancer. Recent studies have revealed associations between hepatic viral infections and extrahepatic cancers. This study aimed to explore the associations between hepatitis B and C viruses and cancer at baseline in the Taiwan Biobank database while controlling for a wide range of confounding variables.
Methods
In a cross-sectional study of adults aged > 20 years, we compared the distribution of demographic factors, lifestyle, and comorbidities between viral and nonviral hepatic groups using the chi-square test. Univariate and multivariate logistic regressions were performed to observe the associations between hepatitis B and C viral infections and cancers by estimating the odds ratio (OR) and 95% confidence interval (CI). Multivariate regression analysis was adjusted for sociodemographic factors, lifestyle, and comorbidities.
Results
From the database, 2955 participants were identified as having HCV infection, 15,305 as having HBV infection, and 140,108 as the nonviral group. HBV infection was associated with an increased likelihood of liver cancer (adjusted OR (aOR) = 6.60, 95% CI = 3.21–13.57, P < 0.001) and ovarian cancer (aOR = 4.63, 95% CI = 1.98–10.83, P = 0.001). HCV infection was observed to increase the likelihood of liver cancer (aOR = 4.90, 95% CI = 1.37–17.53, P = 0.015), ovarian cancer (aOR = 8.50, 95% CI = 1.78–40.69, P = 0.007), and kidney cancer (aOR = 12.89, 95% CI = 2.41–69.01, P = 0.003).
Conclusion
Our findings suggest that hepatic viral infections are associated with intra- and extrahepatic cancers. However, being cross-sectional, causal inferences cannot be made. A recall-by-genotype study is recommended to further investigate the causality of these associations.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. World Health Organization: Hepatitis. 2023. https://www.who.int/health-topics/hepatitis#tab=tab_1. Accessed 18 March 2023.
2. World Health Organization: Hepatitis B. 2022. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed 26 May 2023.
3. World Health Organization: Hepatitis C. 2022. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. Accessed 26 May 2023.
4. Hu YC, Yeh CC, Chen RY, Su CT, Wang WC, Bai CH, et al. Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program. PeerJ. 2018. https://doi.org/10.7717/peerj.4297.
5. Wait S, Chen DS. Toward the eradication of hepatitis B in Taiwan. Kaohsiung J Med Sci. 2012. https://doi.org/10.1016/j.kjms.2011.10.027.